Canadian Journal of Gastroenterology and Hepatology / 2019 / Article / Tab 2

Research Article

Phosphorylation of p53 Serine 15 Is a Predictor of Survival for Patients with Hepatocellular Carcinoma

Table 2

Frequency of PCNA, p21, p53, p53 Ser15-P, and p53 Ser392-P expression and scoring of p53 Ser15-P.

Patient status (n = 199)n%

PCNA status (cut-off 10%)
 Positive (>10%)15175.9
 Negative (<10%)4824.1
p21 status (cut-off 1%)
 Positive (>1%)7135.7
 Negative (<1%)12864.3
p53 status (cut-off 1%)
 Positive (>1%)13567.8
 Negative (<1%)6432.2
p53 Ser392-P status (cut-off 1%)
 Positive (>1%)3015.1
 Negative (<1%)16984.9
p53 Ser15-P status (cut-off 1%)
  Positive (>1%)9447.2
  Negative (<1%)10552.8
p53 Ser15-P status by percentage of positive
  Score 0 (<1%)10552.8
  Score 1 (1-4%)4824.1
  Score 2 (5–19%)4020.1
  Score 3 (20-69%)52.5
  Score 4 (70-100%)10.5

Scoring of HCC patients based on standard in Figure 1; n, number of cases; %, percentage of cases.

We are committed to sharing findings related to COVID-19 as quickly as possible. We will be providing unlimited waivers of publication charges for accepted research articles as well as case reports and case series related to COVID-19. Review articles are excluded from this waiver policy. Sign up here as a reviewer to help fast-track new submissions.